Gelesis Holdings, Inc.
GLSHDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805087
Gelesis Holdings, Inc. was delisted in 2023; its insiders filed their last Form 4 on Sep 21, 2023; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Gelesis Holdings, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
GLSH is no longer listed, so this page shows Q3 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 0
- −2 vs. Q2 2023
- Shares held
- 0
- −430 (−100.0%) vs. Q2 2023
- Total value
- $0
- −$16 (−100.0%) vs. Q2 2023
- New holders
- 0
- 0 more added
- Sold out
- 2
- 0 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GLSH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 2 | $16 |
| Q1 2023 | 39 | $3.55M |
| Q4 2022 | 39 | $3.22M |
| Q3 2022 | 38 | $13.2M |
| Q2 2022 | 38 | $15.0M |
| Q1 2022 | 26 | $41.8M |
| Q4 2021 | 3 | $19.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Gelesis Holdings, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −378−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −52−100.0% | Sold out |